CC2018: Creating Synergy: Early Integration of Palliative Care with Complex Surgical Care (PA)
This session has been identified and designated as Credit to Address Regulatory Mandate for Palliative Care.
Early integration of palliative care is associated with improved quality of life, reduced costs, and longer survival in patients with advanced cancer and chronic progressive disease. Core principles include: management of symptoms and suffering, building personal resilience, discussions of patients’ goals of care, and training in advanced communication skills. How this may apply to complex surgical patients with more acute problems and during discrete episodes of care has yet to be defined. This panel includes established and emerging evidence for initiatives that upstream palliative care into surgical populations: screening and early intervention in surgical intensive care unit (ICU) patients, decision making that balances expectations about preand postoperative risks for complex elective surgery, and transitional models of care in advanced cancer when new treatments make outcomes uncertain.
Alexandra M. Easson, MD, FACS, Toronto, ON
- Palliative Care in Trauma: The First 48 Hours
Herb A. Phelan, MD, MSCS, FACS, Dallas, TX
- High-Risk Surgery: Preoperative Decision Making
Margaret L. Schwarze, MD, FACS, Madison, WI
- Determining Goals of Care in the Surgical Intensive Care Unit
Anne C. Mosenthal, MD, FACS, Newark, NJ
- Early Integration of Palliative Care in Complex Surgical Oncology
Phillippa Hawley, BMed, FRCPC, Vancouver, BC
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
(Download the full list of disclosures.)
Faculty and Disclosures
Alexandra M. Easson, MD, FACS, Toronto, ON - No Disclosures
Herb A. Phelan, MD, MSCS, FACS, Dallas, TX - No Disclosures
Margaret L. Schwarze, MD, FACS, Madison, WI - No Disclosures
Anne C. Mosenthal, MD, FACS, Newark, NJ - No Disclosures
Phillippa Hawley, BMed, FRCPC, Vancouver, BC - Shares in NexPep
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - No Disclosures
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - No Disclosures
David C. Borgstrom, MD, FACS, Morgantown, WV - No Disclosures
Daniel L. Dent, MD, FACS, San Antonio, TX - No Disclosures
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Audra A. Duncan, MD, FACS, London, ON - No Disclosures
Mariam F. Eskander, MD, Boston, MA - No Disclosures
Paula Ferrada, MD, FACS, Richmond, VA - No Disclosures
Neil H. Hyman, MD, FACS, Chicago, IL - No Disclosures
Martin S. Karpeh, Jr., MD, FACS, New York, NY - No Disclosures
Dennis H. Kraus, MD, FACS, New York, NY - No Disclosures
Kenneth W. Sharp, MD, FACS, Nashville, TN - No Disclosures
David A. Spain, MD, FACS, Stanford, CA - No Disclosures
Mary T. Hawn, MD, FACS, Stanford, CA - No Disclosures
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - No Disclosures
Barbara Lee Bass, MD, FACS, FRCS(Hon), Houston, TX - No Disclosures
Quan-Yang Duh, MD, FACS, San Francisco, CA - No Disclosures
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - No Disclosures
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - No Disclosures
Valerie W. Rusch, MD, FACS, New York, NY - No Disclosures
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons, as the accredited provider of this activity, must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest. Therefore, it is mandatory that both the program planning committee and speakers complete disclosure forms. Members of the program committee and speakers were required to disclose all financial relationships. The ACCME defines a ‘commercial interest’ as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients”. It does not consider providers of clinical service directly to patients to be commercial interests. The ACCME considers “relevant” financial relationships as financial transactions (in any amount) that may create a conflict of interest and occur within the 12 months preceding the time that the individual is being asked to assume a role controlling content of the educational activity.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the session. The planning committee members and speakers were contacted and the conflicts listed below have been managed to our satisfaction. However, if you perceive a bias during a session, please advise us of the circumstances on the session evaluation form.
Please note we have advised the speakers that it is their responsibility to disclose at the start of their presentation if they will be describing the use of a device, product, or drug that is not FDA approved or the off-label use of an approved device, product, or drug or unapproved usage.
The requirement for disclosure is not intended to imply any impropriety of such relationships, but simply to identify such relationships through full disclosure, and to allow the audience to form its own judgments regarding the presentation.
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Self Assessment Credit
- 1.50 Certificate of Completion